We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Ortin Laboratories Limited manufactures and trades in pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders. It provides formulations, such as anti diabetics, anti allergics, sedatives and tranquilisers, anti helmenthetics, analgesics and antipyretics, anti biotics-quinolones, anti biotic-pencillins, antifungal, cephalosporins, and macrolides; and anti anginal and cardio vascular, and antifungal products. The company's formulations also include chemo therapeutics, antacids and anti ulcerants, anti spasmodics, calcium preparations, iron preparations, anti arthritic drugs, protein supplements, enzymes, and vitamins, as well as psychiatry, appetizer, gynaec, and anti retroviral products. In addition, it provides active pharmaceutical ingredient (API) intermediates comprising anti retro viral, anti diabetics, analgesics and antipyretics, anti biotic, antifungal, antacids and anti ulcerants, and anti malarials; and manufactures fine chemicals, and grignard and alkali metal products. Further, the company offers services in the areas of process development, process characterization, analytical research and development, assay development, and product characterization; and diagnostic services, including development of rapid flow kits, assays, and reagents. Additionally, it undertakes long-term contracts for manufacturing intermediates and developing new APIs; and operates as a merchant exporter of pharmaceutical finished formulations. Ortin Laboratories Limited was incorporated in 1986 and is headquartered in Hyderabad, India.
TODAY'S HIGH
21.45
TODAY'S LOW
21
52 WEEK HIGH
39.85
52 WEEK LOW
19.3
% of Shares Held by
All Insider
27.71%
% of Shares Held by
Institutions
0.00%
% of Float Held by
Institutions
0.00%
Number of Institutions
Holding Shares
0
MARKET CAP
17.15 Cr.
ETERPRISE VALUE
22.75 Cr.
NO. OF SHARES
81.31 Lakhs
BOOK VALUE
13.536
DIV. YIELD
None%
DEBT
6.14 Cr.
GROSS PROFIT
3.77 Cr.
CASH
59.51 Lakhs
REVENUE
8.42 Cr.
REVENUE/SHARE
10.355
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 0 | 6.95 Lakhs | -7.74 Lakhs | -12.77 Lakhs |
| Change To Liabilities | -55.10 Lakhs | -58.66 Cr. | 12.40 Cr. | 31.01 Cr. |
| Total cashflows from Investing Activities | -12.53 Lakhs | 6.95 Lakhs | -3.09 Cr. | -3.26 Cr. |
| Net Borrowings | 28.75 Lakhs | -2.06 Cr. | 1.87 Cr. | 32.92 Lakhs |
| Total Cash from Financing Activities | -47.54 Lakhs | -9.85 Cr. | -1.33 Cr. | -2.88 Cr. |
| Other Liabilities | 1.35 Cr. | -5.90 Cr. | -2.12 Cr. | -2.19 Cr. |
| Total Assets | 0 | 0 | 0 | 0 |
| Net Income | -39.87 Lakhs | 94.54 Lakhs | -56.39 Lakhs | 1.27 Cr. |
| Change in Cash | 1.55 Cr. | 8.24 Cr. | -1.12 Cr. | 36.88 Lakhs |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 2.15 Cr. | 18.03 Cr. | 3.30 Cr. | 6.52 Cr. |
| Depreciation | 29.38 Lakhs | 28.54 Lakhs | 1.95 Cr. | 1.75 Cr. |
| Other Cashflows from Investing Activities | 0 | 0 | 10.44 Lakhs | 10.44 Lakhs |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Change to Inventory | 9.08 Lakhs | 48.06 Cr. | -12.94 Cr. | -12.93 Cr. |
| Change to Account Receivables | 67.87 Lakhs | 33.23 Cr. | 67.75 Lakhs | -15.98 Cr. |
| Other Cashflows from Financing Activities | -76.29 Lakhs | -7.79 Cr. | -3.20 Cr. | -3.21 Cr. |
| Change to Net Income | 67.93 Lakhs | 6.45 Lakhs | 3.90 Cr. | 3.59 Cr. |
| Capital Expenditures | -12.53 Lakhs | -12.53 Lakhs | -3.12 Cr. | -3.13 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | -52.99 Lakhs | 13.64 Lakhs | 71.85 Lakhs | 1.83 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 28.06 Lakhs | 1 Cr. | 3.80 Cr. | 4.92 Cr. |
| Selling General Administrative | 95.03 Lakhs | 1.36 Cr. | 5.79 Cr. | 4.33 Cr. |
| Gross Profit | 3.77 Cr. | 4.07 Cr. | 41.61 Cr. | 31.99 Cr. |
| Ebit | 28.06 Lakhs | 1 Cr. | 3.80 Cr. | 4.92 Cr. |
| Operating Income | 28.06 Lakhs | 1 Cr. | 3.80 Cr. | 4.92 Cr. |
| Other Operating Expenses | 2.24 Cr. | 1.41 Cr. | 30.05 Cr. | 20.97 Cr. |
| Interest Expense | -81.06 Lakhs | -87.34 Lakhs | -3.20 Cr. | -2.74 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | -13.12 Lakhs | -80.90 Lakhs | 1.28 Cr. | 55.79 Lakhs |
| Total Revenue | 8.42 Cr. | 8.21 Cr. | 197.43 Cr. | 167.76 Cr. |
| Total Operating Expenses | 8.14 Cr. | 7.20 Cr. | 193.63 Cr. | 162.83 Cr. |
| Cost of Revenue | 4.65 Cr. | 4.14 Cr. | 155.82 Cr. | 135.76 Cr. |
| Total Other Income Expense Net | -81.05 Lakhs | -87.34 Lakhs | -3.08 Cr. | -3.08 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | -39.87 Lakhs | 94.54 Lakhs | -56.39 Lakhs | 1.27 Cr. |
| Net Income Applicable to Common Shares | -39.87 Lakhs | 94.54 Lakhs | -56.39 Lakhs | 1.27 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 0 | 0 | 0 | 0 |
| Capital Surplus | 0 | 0 | 0 | 0 |
| Total Liabilities | 9.74 Cr. | 9.91 Cr. | 92.70 Cr. | 79.99 Cr. |
| Stock Holder Equity | 10.95 Cr. | 11.35 Cr. | 23.81 Cr. | 25.09 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 2.40 Cr. | 20.34 Lakhs | 6.39 Cr. | 6.92 Cr. |
| Total Assets | 20.70 Cr. | 21.26 Cr. | 116.51 Cr. | 105.08 Cr. |
| Common Stock | 8.13 Cr. | 8.13 Cr. | 16.94 Cr. | 16.94 Cr. |
| Retained Earnings | 0 | 2.57 Cr. | 6.01 Cr. | 7.29 Cr. |
| Other Liabilities | 40.84 Lakhs | 58.25 Lakhs | 3.97 Cr. | 3.07 Cr. |
| Good Will | 0 | 0 | 0 | 0 |
| Treasury Stock | 2.82 Cr. | 64.52 Lakhs | 85.75 Lakhs | 85.75 Lakhs |
| Other Assets | 31.73 Lakhs | 33.43 Lakhs | 1.15 Cr. | 1.14 Cr. |
| Cash | 59.51 Lakhs | 17.60 Lakhs | 2.49 Cr. | 89.08 Lakhs |
| Current Liabilities | 7.61 Cr. | 7.88 Cr. | 83.82 Cr. | 72.17 Cr. |
| Long Term Asset Charges | 0 | 0 | 0 | 0 |
| Short Long Term Debt | 0 | 0 | 0 | 2.68 Cr. |
| Other Stockholder Equity | 2.82 Cr. | 64.52 Lakhs | 85.75 Lakhs | 85.75 Lakhs |
| Property Plant Equipment | 14.63 Cr. | 14.80 Cr. | 22.88 Cr. | 21.82 Cr. |
| Total Cur. Assets | 5.74 Cr. | 6.12 Cr. | 92.41 Cr. | 82.04 Cr. |
| Long Term Investments | 0 | 1.59 Hundreds | 6.96 Lakhs | 8.40 Lakhs |
| Net Tangible Assets | 10.95 Cr. | 11.35 Cr. | 23.81 Cr. | 25.09 Cr. |
| Short Term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 3.23 Cr. | 3.91 Cr. | 37.32 Cr. | 39.95 Cr. |
| Long Term Debt | 1.72 Cr. | 1.44 Cr. | 4.90 Cr. | 4.73 Cr. |
| Inventory | 1.74 Cr. | 1.83 Cr. | 49.90 Cr. | 36.95 Cr. |
| Accounts Payable | 78.74 Lakhs | 1.33 Cr. | 60 Cr. | 47.59 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account